Rh
RH · NYSE
11/1/2025 | 8/2/2025 | 5/3/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.74 | 0.03 | -2.68 | -2.41 |
| FCF Yield | 2.57% | 2.22% | 0.85% | -0.89% |
| EV / EBITDA | 43.17 | 38.59 | 78.58 | 114.30 |
| Quality | ||||
| ROIC | 2.09% | 2.43% | 1.05% | 2.93% |
| Gross Margin | 44.10% | 45.52% | 43.66% | 44.66% |
| Cash Conversion Ratio | 3.64 | 2.66 | 10.78 | -1.35 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.63% | 1.61% | -1.04% | -3.96% |
| Free Cash Flow Growth | -0.49% | 166.54% | 144.94% | 27.43% |
| Safety | ||||
| Net Debt / EBITDA | 12.62 | 9.40 | 40.38 | 38.12 |
| Interest Coverage | 1.85 | 2.25 | 0.96 | 1.21 |
| Efficiency | ||||
| Inventory Turnover | 0.56 | 0.51 | 0.46 | 0.44 |
| Cash Conversion Cycle | 165.80 | 147.05 | 168.27 | 167.68 |